Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis

Running, not enrolling · Phase 3 · Has a placebo group

Conditions studied: Ulcerative Colitis

In brief

The primary objective of this study is to observe the long-term safety of filgotinib in adults who have completed or met protocol specified efficacy discontinuation criteria in a prior filgotinib treatment study in ulcerative colitis (UC).

Key facts

Study ID
NCT02914535
Run by
Alfasigma S.p.A.
People needed
1173
Starts
2017-02-23
Expected to finish
2026-09-01
Last updated by the study team
2026-05-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.